Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tripartite motif containing 60 pseudogene 17 (TRIM60P17) is a human pseudogene related by sequence to the TRIM60 gene, which encodes a member of the tripartite motif-containing (TRIM) protein family. Unlike functional TRIM proteins, TRIM60P17 is considered a “unitary” or “processed” pseudogene and is not expected to produce a functional protein. There is no evidence that TRIM60P17 is transcribed or has specific regulatory functions, and it is not associated with known diseases, biomarkers, or drug actions. Pseudogenes overall can occasionally play roles in gene regulation by serving as RNA molecules that compete for microRNAs or other regulatory factors, but no specific data is available for TRIM60P17 and it is not considered a therapeutic target[1][2][3].
Not applicable (since not a drug target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tripartite motif containing 60 pseudogene 17 (TRIM60P17).